CannPal

Argent BioPharma strikes binding deal to take on AusCann's assets and intellectual property

Finance

Argent BioPharma strikes binding deal to take on AusCann's assets and intellectual property

August 19, 2025

AusCann's proposed acquisition stalls amid German legalisation uncertainty

Finance

AusCann's proposed acquisition stalls amid German legalisation uncertainty

May 01, 2023

AusCann sells majority CannPal stake back to founder Layton Mills in bid to revive animal health unit

Finance

AusCann sells majority CannPal stake back to founder Layton Mills in bid to revive animal health unit

March 13, 2023

Recent developments from Emyria, Incannex, Epsilon, and AusCann

Finance

Recent developments from Emyria, Incannex, Epsilon, and AusCann

March 08, 2022

Your daily dose of cannabis news: the US$130billion industry; Bod's share price surge; CannPal's breakthrough; Elixinol Global's HFA update; Cannasouth does Colorado deal; Aphria and Aurora merger off

General

Your daily dose of cannabis news: the US$130billion industry; Bod's share price surge; CannPal's breakthrough; Elixinol Global's HFA update; Cannasouth does Colorado deal; Aphria and Aurora merger off

July 22, 2020